Aesica invests £3m in high containment facility

Published: 17-Aug-2010
Containment Manufacturing Ingredients Packaging Regulatory Research & Development Cleaning

Will enable the firm to manufacture potent drugs from May 2011

UK pharmaceutical manufacturer Aesica is investing £3m in a new high containment facility, significantly extending its capabilities in the formulation and packaging of liquid and solid dosage forms.

Aesica estimates that the facility, housed in a purpose-built facility at its Queenborough, Kent site, will be completed by May 2011 and once operational will manufacture potent drugs typically classed as Safebridge category 3. The facility will also include security measures to enable it to produce Schedule II controlled drugs such as opiates.

Suites for granulation, tabletting and blister packing, plus appropriate HVAC and cleaning facilities will be built in the high containment unit. It will be separate from the rest of the company’s facilities to prevent cross-contamination.

Adam Sims, Aesica’s commercial director, said: ‘Our service offering and capability is the most advanced in the UK and the addition of the new facility will be of huge benefit to our current clients and indeed all pharmaceutical companies who require potent drug product production.’

Aesica supplies contract development and contract manufacturing services for active pharmaceutical ingredients and formulated products to the world’s leading pharmaceutical companies and emerging biotechnology organisations.

  • Companies:
  • Aesica Pharmaceuticals
See more

You may also like

Manufacturing

Aesica extends aseptic facilities to include pre-filled syringes

Read more
Batches can be delivered worldwide for clinical trials and within EU for small-scale commercial production

Trending Articles

  1. GMP Annex 1: Validation of disinfectants on cleanroom surfaces Published in August 2022, for implementation in August 2023, Karen Rossington from Contec looks at the revised version of EU GMP Annex 1 expanded and clarified the regulatory requirements of cleaning and disinfection in life science cleanrooms
  2. Samsung Electronics acquires Europe’s largest HVAC company Samsung Electronics has completed the acquisition of FläktGroup to strengthen global position in heating, ventilation and air conditioning markets
  3. Airkey delivers a rapid modular clinic build in Cambodia A prefabricated ISO 7 surgical suite is installed and commissioned in just 20 days using a local crew
  4. Incubating settle plates: Understanding growth patterns and when things are going wrong Steven Brimble from Cherwell Laboratories discusses why it is important to your environmental monitoring regime to understand growth characteristics of common cleanroom contaminants and how morphology shifts over time on various media
  5. Achieve Annex 1 compliance: master cleanroom CCS & PPE Despite widespread training and updated SOPs, personnel remain the #1 contamination risk in aseptic environments (Annex 1, Section 7)

Upcoming event

CPhI Middle East

8–10 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

Manufacturing

Aesica extends aseptic facilities to include pre-filled syringes

Batches can be delivered worldwide for clinical trials and within EU for small-scale commercial production
Containment

Achieve Annex 1 compliance: master cleanroom CCS & PPE

Despite widespread training and updated SOPs, personnel remain the #1 contamination risk in aseptic environments (Annex 1, Section 7)
Design & Build

Airkey delivers a rapid modular clinic build in Cambodia

A prefabricated ISO 7 surgical suite is installed and commissioned in just 20 days using a local crew
HVAC

Samsung Electronics acquires Europe’s largest HVAC company

Samsung Electronics has completed the acquisition of FläktGroup to strengthen global position in heating, ventilation and air conditioning markets
Design & Build

Guardtech supports malaria fight in Djibouti with 11-bay portable lab

Cleancube Multi solution deployed for Oxitec’s Friendly mosquito programme
Sustainability

Micronclean launches Project Phoenix to transform its Louth facility

£7 million investment to modernise cleanroom laundry operations and boost sustainability
Containment

AST X CURIS: A new phase of decontamination

The Atmos™ Isolator features industry-leading automated decontamination technology from CURIS System, which uses a low-concentration application of Vapor Phase Hydrogen Peroxide (VPHP). The innovative 7000ei system integrates seamlessly with AST technology for a unified, single point of operation. The patented Rapid Vapor™ system with 7% CURoxide™ provides industry-leading decontamination cycle times and prioritizes production uptime and the life of your fill-finish equipment
Subscribe now